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Abstract Although a growing number of reports on the 
bioactivities of sphingosine 1-phosphate (Sph-l-P) in various 
systems have been appearing recently, current evidence for the 
involvement of Sph-l-P in signal transduction or cellular 
function(s) consists largely of data on cellular and biochemical 
effects of exogenous Sph-l-P. In this study, we measured Sph-1-
P contents in various rat tissues. When the amount of this 
sphingoid base was measured by its A'-acetylation into |3H]C2-
ceramide 1-phosphate with |3H]acetic anhydride, we could detect 
Sph-l-P in all rat tissues examined. We also got unexpected 
findings that Sph-l-P exists most abundantly in testis = intesti-
ne > spleen (in the order of Sph-l-P abundance when its amounts 
were adjusted to the phospholipid levels). Our new data on Sph-1-
P distribution in rat tissues may imply novel bioactivities for Sph-
l -P . 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The phosphorylated sphingoid base sphingosine 1-phos-
phate (Sph-l-P) is the initial product of the catabolism of 
sphingosine (Sph) by Sph kinase and has recently been added 
to the list of bioactive sphingolipids [1,2]. Sph- l -P has been 
shown to be involved in a variety of cellular functions, includ-
ing the stimulation of fibroblast growth [3,4], regulation of cell 
motility [5,6], platelet activation [7], activation of muscarinic 
K + currents [8], mediation of FceRI antigen receptor signal-
ing [9], neurite retraction [10], and the suppression of ceram-
ide-mediated apoptosis [11]. It is now widely accepted that 
Sph- l -P itself has physiologic functions in addition to its 
role as a metabolite of Sph. 
Although the physiological roles of Sph- l -P are strongly 
suggested, current evidence for the involvement of Sph- l -P 
in signal transduction or cellular function(s) consists largely 
of data on cellular and biochemical effects of exogenous Sph-
l-P. Few studies have reported the presence and quantitative 
changes of Sph- l -P in cells or tissues under physiological con-
ditions. To obtain clear evidence implicating endogenous Sph-
l-P in signal transduction and to assess its physiological and 
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pathophysiological functions, we recently developed a facile 
and sensitive method for quantification of Sph-1 -P by its acyl-
ation into Ar-[3H]acetylated Sph- l -P ([3H]C2-ceramide 1-phos-
phate) with [3H]acetic anhydride [12]. Using this assay meth-
od, blood platelets were found to contain high levels of Sph-1-
P [7,12], which is in agreement with the facts that platelets 
possess high Sph kinase activity and lack Sph- l -P lyase activ-
ity [13-15]. In this study, we measured Sph- l -P contents in 
various rat tissues. 
2. Materials and methods 
2.1. Sph-l-P extraction from rat tissues 
The following tissues were obtained from Wistar rats (male, if not 
indicated): spleen, testes, muscle, kidney, heart, lung, liver, brain, 
intestine, and ovaries. The tissues were drained of blood, rinsed in 
cold physiological salt solution, and cut into smaller pieces. Weighed 
tissue samples were homogenized using a Brinkman Homogenizer in 
6 ml of ice-cold chloroform/methanol (1:2). This was followed by 
thorough mixing and sonication for 30 min. After the addition of 
4 ml of chloroform, 4 ml of 1 M KC1, and 150 ul of 7 N NH4OH, 
the samples were thoroughly mixed and the phases separated by cen-
trifugation. The lower chloroform phases were saved for the phospho-
lipid determination. The alkaline upper phases were transferred to 
new tubes, into which 6 ml of chloroform and 300 ul of concentrated 
HC1 were added. The samples were thoroughly mixed and the phases 
separated by centrifugation. The resultant upper phases were dis-
carded and the lower chloroform phases were transferred to new tubes 
and evaporated to dryness under a flow of nitrogen. This was fol-
lowed by a rinse of chloroform, evaporation to dryness, a rinse of 
ethanol, and a final evaporation. The samples were then assayed for 
Sph-l-P as described below. 
2.2. Quantitative measurement of Sph-l-P 
Sph-l-P was quantitatively measured by its 7V-acylation with 
[3H]acetic anhydride into /V-[3H]acetylated Sph-l-P ([3H]C2-ceramide 
1-phosphate) as described previously [12]. The amounts of Sph-l-P 
extracted were calculated by extrapolation from Sph-l-P standards 
run through the same procedures. 
2.3. Phospholipid quantitation 
The lower chloroform phases from the first extraction of the tissue 
samples were assayed for phosphorus content. This was performed by 
the method of Chen et al. [16]. 
3. Results and discussion 
When a mass-spectrometric approach was applied to ana-
lyze Sph-l -P, its presence in rat tissues was demonstrated in 
the abundance order of brain > kidney > liver (adjusted to the 
wet tissue weights) [17]. Our results with the use of a newly-
developed assay method were consistent with this rough esti-
mation reported. That is, Sph- l -P exists in those tissues in the 
order of brain > kidney > liver, when the amount of this 
sphingoid base was measured by its A'-acylation into 
[3H]C2-ceramide 1-phosphate with [3H]acetic anhydride and 
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adjusted to the wet tissue weights (Fig. 1). However, we also 
got unexpected findings that Sph-l-P exists more abundantly 
in testis, intestine, and spleen (Fig. 1). When Sph-l-P amounts 
were adjusted to the phospholipid levels, its contents in these 
three tissues were much higher than that in brain (in the order 
of testis = intestine > spleen) (Fig. 2). 
One possible explanation for Sph-l-P abundance in spleen 
is that this organ is a reservoir for blood cells, including plate-
lets, which are highly abundant in Sph-l-P. However, at the 
present stage, we do not have a clear answer to the question 
why Sph-l-P is abundantly present in testis. We also examined 
Sph-l-P content in the ovary of female Wistar rats. The values 
(=5 25 nmol Sph-1-P/wet tissue weight in grams or 0.1 mol% 
Sph-1-P/phospholipid) were much lower than those in testis. 
Accordingly, testis, as a reproductive gland, is specifically rich 
in Sph-l-P. We have no good explanation for Sph-l-P abun-
dance in intestine, either. The most important information, we 
believe, is Sph-l-P localization in these tissues. For this pur-
pose, we are aiming generation of anti-Sph-1-P antibody. 
We could detect Sph-l-P in all rat tissues examined (Figs. 1 
and 2). Among those, Sph-l-P content was extremely low in 
liver. This may be related to the fact that the lyase activity for 
Sph-l-P degradation is very high in this organ [18]. On the 
contrary, we previously found that in human platelets lacking 
the lyase, Sph-l-P content is high and that accumulated Sph-
l-P is released upon stimulation, resulting the accelation of 
thrombosis [7]. 
A growing number of reports on the bioactivities of Sph-1-
P in various systems have been appearing recently. The in-
volved cells or tissues are hematopoietic cells [7,9,11], mela-
noma cells [5], neuronal cells [10], fibroblasts [3,4], smooth 
muscle cells [6], and atrial myocytes [8]. However, in our 
knowledge, this is the first report to have measured the tissue 
distribution of Sph-l-P thoroughly. Our new data, the high 
Sph-l-P content in intestine and testis, might deserve special 
100 
Fig. 1. Sph-l-P contents (nmol/tissue weight) in various rat tissues. 
Sph-l-P extracted from various rat tissues was measured and ad-
justed to the wet tissue weights. Values are the means ± SD (n - 3 
for heart and n = 4 for all other organs). 
Fig. 2. Sph-l-P contents (mol%/phospholipid) in various rat tissues. 
Sph-l-P extracted from various rat tissues was measured and ad-
justed to the phospholipid levels. Values are means ±SD (« = 3 for 
heart and « = 4 for all other organs). 
attention to get insights into novel bioactivities for Sph-l-P in 
these tissues or others. 
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